Globeflex Capital’s Boston Scientific BSX Stock Holding History

Globeflex Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-68,851	Closed	-$1.13M	–	447
2015 Q3	$1.13M	Hold	68,851	–	–	0.24%	129
2015 Q2	$1.22M	Sell	68,851 -24,218	-26%	-$433K	0.22%	163
2015 Q1	$1.65M	Hold	93,069	–	–	0.31%	99
2014 Q4	$1.23M	Sell	93,069 -294,328	-76%	-$3.76M	0.24%	157
2014 Q3	$4.58M	Buy	387,397 +6,216	+2%	+$78.3K	0.52%	87
2014 Q2	$4.87M	Buy	+381,181	New	+$4.96M	0.53%	76

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Globeflex Capital's BSX Position: Q4 2015 in Review

Globeflex Capital sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 68,851 shares — an estimated $1.13M sold.

Globeflex Capital first reported a position in BSX in Q2 2014 and held it in 6 quarters. The position peaked at $4.87M in Q2 2014. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

Globeflex Capital reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
Globeflex Capital sold 68,851 Boston Scientific shares in Q4 2015, an estimated $1.13M.
Globeflex Capital first reported a position in Boston Scientific in Q2 2014 and held it in 6 quarters.
Globeflex Capital's Boston Scientific position peaked at $4.87M in Q2 2014.
502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on Globeflex Capital's 13F filing for Q4 2015, filed 10 Feb 2016.